Case report by Toce and co-authors: Have all the reasons for poor morphine glucuronidation been addressed?
作者信息
Finel Moshe, Järvinen Erkka
机构信息
Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
出版信息
Br J Clin Pharmacol. 2019 Apr;85(4):859-860. doi: 10.1111/bcp.13868. Epub 2019 Feb 8.
Abstract
摘要
相似文献
1
Case report by Toce and co-authors: Have all the reasons for poor morphine glucuronidation been addressed?托塞及其共同作者的病例报告：吗啡葡萄糖醛酸化不良的所有原因都已得到探讨了吗？
Br J Clin Pharmacol. 2019 Apr;85(4):859-860. doi: 10.1111/bcp.13868. Epub 2019 Feb 8.
2
Prolonged central apnoea after intravenous morphine administration in a 12-year-old male with a UGT1A1 loss-of-function polymorphism.静脉注射吗啡后，12 岁男性 UGT1A1 失功能多态性患者发生长时间中枢性呼吸暂停。
Br J Clin Pharmacol. 2019 Jan;85(1):258-262. doi: 10.1111/bcp.13779. Epub 2018 Nov 12.
3
Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.鼠 UDP-葡糖醛酸基转移酶（UGT）2b1 和 1a1 的异寡聚体形成导致对吗啡的葡糖醛酸化活性增加，而这种活性在任何一种 UGT 的同寡聚体中都不存在。
Biochem Biophys Res Commun. 2020 Apr 30;525(2):348-353. doi: 10.1016/j.bbrc.2020.02.075. Epub 2020 Feb 21.
4
Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties.尿苷二磷酸葡萄糖醛酸基转移酶1A1和1A8对吗啡-6-葡萄糖醛酸化的贡献及其动力学特性。
Drug Metab Dispos. 2008 Apr;36(4):688-94. doi: 10.1124/dmd.107.019281. Epub 2008 Jan 10.
5
In vitro evidence for the involvement of at least two forms of human liver UDP-glucuronosyltransferase in morphine 3-glucuronidation.体外实验证据表明，至少两种形式的人肝脏UDP-葡萄糖醛酸基转移酶参与了吗啡3-葡萄糖醛酸化反应。
Biochem Pharmacol. 1988 Jul 15;37(14):2839-45. doi: 10.1016/0006-2952(88)90048-2.
6
Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.评估3'-叠氮-3'-脱氧胸苷、吗啡和可待因作为人肝微粒体中尿苷二磷酸葡萄糖醛酸基转移酶2B7（UGT2B7）的探针底物：UGT2B7*2多态性的特异性及影响
Drug Metab Dispos. 2003 Sep;31(9):1125-33. doi: 10.1124/dmd.31.9.1125.
7
The enantioselective glucuronidation of morphine in rats and humans. Evidence for the involvement of more than one UDP-glucuronosyltransferase isoenzyme.大鼠和人类体内吗啡的对映体选择性葡萄糖醛酸化。涉及一种以上尿苷二磷酸葡萄糖醛酸基转移酶同工酶的证据。
Biochem Pharmacol. 1989 Oct 1;38(19):3273-80. doi: 10.1016/0006-2952(89)90625-4.
8
Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode.酮康唑对UDP-葡萄糖醛酸基转移酶2b7催化的吗啡葡萄糖醛酸化的抑制作用：涉及一种新型非竞争性模式的双重机制。
Drug Metab Dispos. 2006 Aug;34(8):1277-82. doi: 10.1124/dmd.106.009738. Epub 2006 May 5.
9
Human UGT2B7 catalyzes morphine glucuronidation.人UGT2B7催化吗啡葡萄糖醛酸化。
Drug Metab Dispos. 1997 Jan;25(1):1-4.
10
Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4.细胞色素P450对尿苷二磷酸葡萄糖醛酸基转移酶功能的调节：细胞色素P450 3A4改变尿苷二磷酸葡萄糖醛酸基转移酶2B7催化的吗啡葡萄糖醛酸化的证据。
Mol Pharmacol. 2005 Mar;67(3):665-72. doi: 10.1124/mol.104.007641. Epub 2004 Dec 20.
本文引用的文献
1
Prolonged central apnoea after intravenous morphine administration in a 12-year-old male with a UGT1A1 loss-of-function polymorphism.静脉注射吗啡后，12 岁男性 UGT1A1 失功能多态性患者发生长时间中枢性呼吸暂停。
Br J Clin Pharmacol. 2019 Jan;85(1):258-262. doi: 10.1111/bcp.13779. Epub 2018 Nov 12.
2
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.《药理学简明指南 2017/18：酶》
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S272-S359. doi: 10.1111/bph.13877.
3
Optimized methods for targeted peptide-based quantification of human uridine 5'-diphosphate-glucuronosyltransferases in biological specimens using liquid chromatography-tandem mass spectrometry.使用液相色谱-串联质谱法对生物样本中基于靶向肽的人尿苷5'-二磷酸葡萄糖醛酸转移酶进行定量的优化方法。
Drug Metab Dispos. 2014 May;42(5):885-9. doi: 10.1124/dmd.113.056291. Epub 2014 Mar 4.
4
Targeted quantitative proteomics for the analysis of 14 UGT1As and -2Bs in human liver using NanoUPLC-MS/MS with selected reaction monitoring.采用纳升超高效液相色谱-串联质谱联用技术（NanoUPLC-MS/MS）结合选择反应监测（SRM）对人肝组织中 14 种 UGT1A 和 UGT2B 进行靶向定量蛋白质组学分析。
J Proteome Res. 2013 Oct 4;12(10):4402-13. doi: 10.1021/pr4004213. Epub 2013 Sep 26.
5
Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation.氯胺酮对人尿苷二磷酸葡糖醛酸基转移酶的体外影响预测了氯胺酮抑制可待因和吗啡葡糖醛酸化所产生的潜在药物相互作用。
Drug Metab Dispos. 2011 Aug;39(8):1324-8. doi: 10.1124/dmd.111.039727. Epub 2011 May 6.
6
Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties.尿苷二磷酸葡萄糖醛酸基转移酶1A1和1A8对吗啡-6-葡萄糖醛酸化的贡献及其动力学特性。
Drug Metab Dispos. 2008 Apr;36(4):688-94. doi: 10.1124/dmd.107.019281. Epub 2008 Jan 10.
7
Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.评估3'-叠氮-3'-脱氧胸苷、吗啡和可待因作为人肝微粒体中尿苷二磷酸葡萄糖醛酸基转移酶2B7（UGT2B7）的探针底物：UGT2B7*2多态性的特异性及影响
Drug Metab Dispos. 2003 Sep;31(9):1125-33. doi: 10.1124/dmd.31.9.1125.
8
Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7.人尿苷二磷酸葡萄糖醛酸基转移酶对吗啡3-和6-葡萄糖醛酸化的同工型选择性及动力学：UGT2B7非典型葡萄糖醛酸化动力学的证据。
Drug Metab Dispos. 2003 Sep;31(9):1086-9. doi: 10.1124/dmd.31.9.1086.
9
Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.导致克里格勒 - 纳贾尔综合征和吉尔伯特综合征的胆红素尿苷二磷酸葡萄糖醛酸基转移酶（UGT1A1）的基因损伤：基因型与表型的相关性
Hum Mutat. 2000 Oct;16(4):297-306. doi: 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z.
Zotero 插件